PremiumThe FlyCardio Diagnostic’s Epi+Gen CHD test available at Meijer Supercenter Cardio Diagnostics achieves SOC 2 Type I compliance certification Cardio Diagnostics price target raised to $2 from $1.35 at Benchmark PremiumCompany AnnouncementsCardio Diagnostics Unveils New Investor Engagement Materials Cardio Diagnostics announces issuance of patent from USPTO Cardio Diagnostics teams with FMS to deploy tests to certain Walmart locations PremiumThe FlyAMA grants Cardio Diagnostics CPT PLA reimbursement code for Epi+Gen CHD Cardio Diagnostics receives noncompliance notification from Nasdaq Cardio Diagnostics unveils PrecisionCHD Epigenetic Test in JAHA 
